Antimicrobial resistance in bacteria

2,094 views 58 slides Mar 31, 2021
Slide 1
Slide 1 of 58
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58

About This Presentation

The basics of Antimicrobial resistance and its effects and prevention.


Slide Content

Antimicrobial Resistance in Bacteria Dr. Suprakash Das Assist. Prof.

WELCOME TO THE TITANIC OF ANTIBIOTICS……!!!!! Alexendra Flamming Discovered the 1 st Antibiotic- Penicillin In 1928

Antimicrobial Agents Antimicrobials are the agents that kill or inhibit the growth of Microorganisms. They can be classified in a variety of ways- Microorganisms against which they are used- Antibacterial/ Antifungal/ Antivirals Ability to kill- - Cidal / -Static According to the source: Natural/ Chemically synthesized. According to chemical structure and mechanism of action.

Mechanism of Action of Antimicrobials

SuperBugs ….!!!

Antimicrobial Resistance Antimicrobial resistance refers to development of resistance to an antimicrobial agent by a microorganism. It can be of 2 types- Acquired Resistance Intrinsic Resistance Acquired Resistance- This refers to the emergence of resistance in the bacteria that are ordinarily susceptible to antimicrobial agents, by acquiring genes coding for resistance. This is the most common type of antibiotic resistance among bacteria. Intrinsic Resistance- It refers to the innate ability of a bacterium to resist a class of antimicrobial agents due to its inherent structural or functional characteristics. (Gram-negative bacteria are resistant to Vancomycin.) This imposes negligible threat as it is a defined pattern of resistance and is non-transferable. However, clinicians must be aware to exclude these antibiotics from therapy.

Intrinsic Antimicrobial Resistance Organism Intrinsic Resistance to Antibiotics Enterobacteriaceae Antibiotics used for Gram Positive Organisms- Exception- Salmonella and Shigella is susceptible to Azithromycin K. pneumoniae Ampicillin, Ticarcillin Citrobacter spp. Ampicillin, 1 st and 2 nd gen. Cephalosporins, Cephamycins , Amoxicillin- Clavulunate / Sulbactum Proteus/ Morganella / Providentia spp./Serratia marcescens Ampicillin, 1 st and 2 nd gen. Cephalosporins, Tetracyclin , Tigecyclin , Nitrofurantoin, Polymyxin-B/E, Colistin Salmonella spp. Aminoglycosides, 1 st and 2 nd gen. Cephalosporins Y. enterocolitica Ampicillin, 1 st and 2 nd gen. Cephalosporins, Cephamycins , Amoxicillin- Clavulunate / Sulbactum , Ticarcillin.

Intrinsic Antimicrobial Resistance Intrinsic Antimicrobial Resistance Organism Intrinsic Resistance to Antibiotics Non- Fermentive Gram Negative Bacteria (NF-GNB) Antibiotics for Gram positive organisms + Penicillin , 1 st and 2 nd Gen. Cephalosporins. P. aeruginosa Ampicillin, Ceftriaxone, Amoxicillin-clavulanate, Ampicillin-Sulbactam, Ertapenem, Cotrimoxazole, Tigecyclin , Chloramphenicol. baumannii “do” + Fosfomycin S. maltophilia / Burkhulderia cephacia complex “do” + Polymyxin + Colistin Enterococcus gallinerum / casseliflavus Vancomycin Enterococcus spp Clindamycin, Cotrimoxazole

Mutational and Transferable Drug Resistance In presence of selective antibiotic pressure , bacteria acquire new genes mainly by 2 broad methods:  Mutational Resistance- Resistance can develop due to mutation of the resident genes. Typically seen in M. tuberculosis, developing resistance to ATT. Usually, it is a low level resistance, developing to one drug at a time which can be overcome by using combination of different classes of antibiotics. This is why multi drug therapy is used in ATT. Transferable drug resistance- It is plasmid coded and usually transferred by Conjugation and rarely by Transduction or Transformation. The resistance coded plasmid (usually called –R plasmid) can carry multiple genes, each coding resistance to one class of antibiotic. It results in high degree of resistance to multiple drugs which can not be overcome by combination of drugs.

What causes Emergence of Antimicrobial Resistance Overuse and misuse of antimicrobial agents is the single most important cause. The evaluation of resistant strains is a natural phenomenon especially when an antibiotic is overused. Use of a particular antibiotic posses selective pressure in a population of bacteria which in turn promotes resistant bacteria to thrive and susceptible bacteria to die off. Thus resistant population flourish in the area of high antimicrobial use. Other important drivers of spread of antimicrobial resistance  Lack of access to clean water Sanitation and hygiene for both humans and animals Poor infection control practices in health care facilities. Poor access to quality and affordable medicines and diagnostics Lack of awareness and knowledge Lack of legislation.

Deaths due to Antimicrobial Resistance by 2050- A Forecast

Mechanism of Antimicrobial Resistance  Decreased permeability across cell wall Certain bacteria modify their cell wall membrane porin channels, either in frequency, size, or selectivity, thereby, preventing antimicrobials into entering in to the cell. Bacteria- Pseudomonas, Enterobacter and Klebsiella spp. Antibiotics- Imipenem, Aminoglycosides, Quinolones. Efflux Pumps Efflux pumps mediate expulsion of drugs from the cells, soon after their entry, thereby preventing the intra-cellular accumulation of drugs. E. coli and Enterobacteriaceae- Tetracycline and Chloramphenicol Staphylococci- Macrolides S. aureus and S. pneumoniae - Fluoroquinolones

Mechanism of Antimicrobial Resistance  Enzymatic Inactivation Certain bacteria can inactive the antimicrobial agent by producing various enzymes such as: Beta Lactamases- Produced by both Gram + ve & - ve organisms. Acts on Beta lactam drugs by breaking the Beta lactam ring. Aminoglycoside modifying enzymes (Acetyl/ Adenyl and Phospho-Transferases) Chloramphenicol Acetyl Transferase- Produced by Enterobacteriaceae. Modification of Target Sites MRSA (Methicillin Resistant Sthaphylococcus aureus )- In this strain, the binding site for Penicillin (PBP) get altered to PBP-2a coded by gene mec A . tHIS altered protein don’t bind penicillin and resist the cell wall formation inhibition by penicillin.

Mechanism of Antimicrobial Resistance  Pneumococci- B- lactam resistance due to altered PBP (PBP-2b) Streptomycin resistance in Mycobacteria due to altered 16s rRNA protein. Rifampicin resistance- Mutation in RNA polymerase Quinolone resistance- Mutation in RNA gyrase enzymes Vancomycin Resistant Enterococci- cHANGES in target site for Vancomycin.

Vancomycin Resistance 

Laboratory Testing for Antimicrobial Resistance- Kirby- Baurer Disc Diffusion Method

Laboratory Testing for Antimicrobial Resistance- Broth Micro Dilution Method

Laboratory Testing for Antimicrobial Resistance- E-test

Laboratory Testing for Antimicrobial Resistance- Automated ID & AST

Gene Sequencing for Antimicrobial Resistance

Line Probe Assay ATT Drugs Resistance Diagnosis

THANK YOU